ClinConnect ClinConnect Logo
Search / Trial NCT06720649

Benefits of Ballistic Tests After the Anterior Cruciate Ligament Surgery

Launched by ALMAVIVA SANTE · Dec 3, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well ballistic tests can predict whether someone will be able to return to physical activities 24 months after having surgery for an anterior cruciate ligament (ACL) injury. Ballistic tests measure fast movements, like jumping and running, which are important for athletes and active individuals. The goal is to find a better way to assess recovery after ACL surgery, since current tests don’t provide enough information about how well a person can stabilize their knee during quick movements.

To participate in this study, you need to be an adult over 18 who has had ACL reconstruction surgery, specifically using hamstrings, and you should not have additional serious injuries or health conditions that could affect your recovery. Participants will take part in specific tests to measure their strength and movement. It’s important to note that this trial is not yet recruiting participants, so there’s no need to apply just yet. If you have any questions about your eligibility or the study itself, it’s best to talk to your healthcare provider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patient (\> 18 years),
  • * Patient who has undergone ACL reconstruction of the hamstrings with or without associated extra-articular plastic surgery:
  • Isolated ACL sprain without injury to the collateral ligaments or the PCL,
  • ACL reconstruction without associated meniscal injury or with repaired or menisctomized meniscal injury,
  • Having to perform a K-STARTS test and an isokinetic test,
  • Having the Tegner score before the rupture.
  • Exclusion Criteria:
  • Patient with high cardio-respiratory risk,
  • Osteoarticular and neuromuscular traumatic sequelae of the lower limbs,
  • Degenerative neuromuscular diseases,
  • Connective Tissue and Collagen Disease (e.g. Marfan),
  • Follow-up of a medical treatment that may influence the neuro-muscular system (e.g., antidepressants, etc.) during the tests,
  • Pregnant, parturient or breastfeeding patient.

About Almaviva Sante

Almaviva Santé is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, Almaviva Santé collaborates with healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. The organization is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while generating robust data to support the development of new therapies. Through its expertise and strategic partnerships, Almaviva Santé aims to contribute significantly to the global medical community and improve patient care.

Locations

Marseille, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported